XML 13 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flow from operating activities    
Net loss $ (28,530) $ (2,312)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation expense 73 88
Amortization expense 65 64
Share-based compensation expense 3,540 4,118
Net foreign exchange impacts 3,020 (355)
Other income, net (969) (667)
Income tax expense 0 244
Change in operating assets and liabilities:    
Decrease/(Increase) in trade receivables 940 (10,012)
Increase in other current assets (592) (768)
Decrease in R&D benefit receivable 8,338 8,786
Decrease in other long-term assets 89 19
Increase/(decrease) in trade and other payables 1,848 (2,849)
Decrease in contract liabilities (72) (5,515)
(Decrease)/increase in operating lease liabilities (59) 16
Net cash (used in) provided by operating activities (12,309) (9,143)
Cash flow from investing activities    
Redemption of term deposits 25,683 0
Purchase of term deposits (70,060) (49,908)
Purchase of property, plant and equipment (4) 0
Net cash (used in) provided by investing activities (44,381) (49,908)
Cash flow from financing activities    
Proceeds from issue of ordinary shares 14 133,020
Net cash provided by financing activities 14 133,020
(Decrease)/increase in cash and cash equivalents (56,676) 73,969
Cash and cash equivalents at start of period 121,330 68,789
Effect of exchange rate fluctuations on cash and cash equivalents held 232 (35)
Cash and cash equivalents, end of period 64,886 142,723
Supplemental disclosures of cash flow information:    
Tax Paid $ (76) $ (109)